The Proton Therapy Center Czech is privately owned and operated. It was developed in partnership with the faculty of medicine at Prague's Charles University and the faculty of nuclear sciences and physical engineering at Czech Technical University. When fully operational, the center is expected to treat about 2,500 cancer patients a year predominantly from the Czech Republic, the Russian Federation, and the rest of Europe.
The center has five patient treatment rooms. The IBA-installed proton beam system includes a cyclotron, beam line, three gantry treatment rooms, and fixed-beam treatment room. IBA's pencil-beam scanning dedicated nozzle technology is also being used.
IBA moves ahead with installation in Belgium, December 14, 2012
Q3 produces revenue gain for IBA, but also loss, November 20, 2012
IBA gets new Rhodotron contracts in Asia, October 12, 2012
IBA, Piramal sign deal on F-18 amyloid imaging, August 8, 2012
IBA agrees to first proton therapy installation in Europe, June 29, 2012